Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (111-120 of 583) with videos related to

Pageof 59
Sort By:
Seminars in Oncology|February 1, 1997
Introduction: acute leukemia: recent advancesC D Bloomfield, G P Herzig, M A Caligiuri
American Journal of Hematology|August 1, 1988
Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up resultsK E Dusenbery, B A Peterson, C D Bloomfield
Annals of Internal Medicine|December 1, 1974
Daunorubicin-prednisone treatment of erythroleukemiaC D Bloomfield, R D Brunning, B J Kennedy
Cancer|August 1, 1975
Nodular lymphoma: bone marrow and blood manifestationsR W McKenna, C D Bloomfield, R D Brunning
British Journal of Haematology|January 1, 1976
Significance of haematological parameters in the non-Hodgkin's malignant lymphomasC D Bloomfield, R W McKenna, R D Brunning
Cancer Research|November 1, 1983
Covalent labeling of rat thymocyte and human lymphoid glucocorticoid receptorC M Foster, H J Eisen, C D Bloomfield
Progress in Clinical and Biological Research|January 1, 1984
Glucocorticoid receptor levels predict response to treatment in human lymphomaC D Bloomfield, A U Munck, K A Smith
Clinical Chemistry|June 1, 1980
DNA nucleotidylexotransferase of normal persons and leukemic patientsW G Yasmineh, B M Smith, C D Bloomfield
Molecular Immunology|September 1, 1991
Expression of the CD15 antigen on normal and leukemic myeloid cells: effects of neuraminidase and variable detection with a panel of monoclonal antibodiesE D Ball, L M Schwarz, C D Bloomfield
Current Opinion in Oncology|October 9, 2008
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaKrzysztof Mrózek, Guido Marcucci, Peter Paschka, et al.
Pageof 59

Showing results (111-120 of 583) with videos related to

Sort By:
Pageof 59
Seminars in Oncology|February 1, 1997
Introduction: acute leukemia: recent advancesC D Bloomfield, G P Herzig, M A Caligiuri
American Journal of Hematology|August 1, 1988
Chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for Hodgkin disease: fourteen-year follow-up resultsK E Dusenbery, B A Peterson, C D Bloomfield
Annals of Internal Medicine|December 1, 1974
Daunorubicin-prednisone treatment of erythroleukemiaC D Bloomfield, R D Brunning, B J Kennedy
Cancer|August 1, 1975
Nodular lymphoma: bone marrow and blood manifestationsR W McKenna, C D Bloomfield, R D Brunning
British Journal of Haematology|January 1, 1976
Significance of haematological parameters in the non-Hodgkin's malignant lymphomasC D Bloomfield, R W McKenna, R D Brunning
Cancer Research|November 1, 1983
Covalent labeling of rat thymocyte and human lymphoid glucocorticoid receptorC M Foster, H J Eisen, C D Bloomfield
Progress in Clinical and Biological Research|January 1, 1984
Glucocorticoid receptor levels predict response to treatment in human lymphomaC D Bloomfield, A U Munck, K A Smith
Clinical Chemistry|June 1, 1980
DNA nucleotidylexotransferase of normal persons and leukemic patientsW G Yasmineh, B M Smith, C D Bloomfield
Molecular Immunology|September 1, 1991
Expression of the CD15 antigen on normal and leukemic myeloid cells: effects of neuraminidase and variable detection with a panel of monoclonal antibodiesE D Ball, L M Schwarz, C D Bloomfield
Current Opinion in Oncology|October 9, 2008
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaKrzysztof Mrózek, Guido Marcucci, Peter Paschka, et al.
Pageof 59